SIMILAR PATTERNS OF AMINO ACIDS FOR 3TOP_B_ACRB1
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1fvp | FLAVOPROTEIN 390 (Photobacteriumphosphoreum) |
no annotation | 5 | ILE A 168ASP A 97ASP A 48PHE A 9HIS A 131 | None | 1.49A | 3topB-1fvpA:2.6 | 3topB-1fvpA:13.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2g3n | ALPHA-GLUCOSIDASE (Sulfolobussolfataricus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 10 | ASP A 87ASP A 212ILE A 249TRP A 284ASP A 320MET A 321ARG A 400ASP A 416PHE A 449HIS A 480 | BOG A2000 (-2.7A)NoneNoneNoneNoneBOG A2000 ( 4.0A)BOG A2000 (-3.1A)BOG A2000 (-3.0A)NoneNone | 0.56A | 3topB-2g3nA:34.9 | 3topB-2g3nA:26.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2g3n | ALPHA-GLUCOSIDASE (Sulfolobussolfataricus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 5 | ASP A 416ASP A 87ARG A 400ASP A 320HIS A 252 | BOG A2000 (-3.0A)BOG A2000 (-2.7A)BOG A2000 (-3.1A)NoneNone | 1.37A | 3topB-2g3nA:34.9 | 3topB-2g3nA:26.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2x2i | ALPHA-1,4-GLUCANLYASE ISOZYME 1 (Gracilariopsislemaneiformis) |
PF01055(Glyco_hydro_31) | 9 | ASP A 239ASP A 412ASP A 553MET A 554LYS A 590ARG A 649ASP A 665PHE A 698HIS A 731 | QPS A1050 (-2.5A)QPS A1050 (-3.2A)QPS A1050 (-3.1A)QPS A1050 (-3.1A)QPS A1050 ( 4.0A)QPS A1050 (-3.2A)QPS A1050 (-2.7A)QPS A1050 (-4.3A)QPS A1050 (-4.3A) | 0.54A | 3topB-2x2iA:32.8 | 3topB-2x2iA:24.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xvg | ALPHA XYLOSIDASE (Cellvibriojaponicus) |
PF01055(Glyco_hydro_31)PF16338(DUF4968)PF17137(DUF5110) | 6 | ASP A 470ASP A 582ARG A 642ASP A 659PHE A 692HIS A 740 | None | 0.68A | 3topB-2xvgA:33.4 | 3topB-2xvgA:24.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xvg | ALPHA XYLOSIDASE (Cellvibriojaponicus) |
PF01055(Glyco_hydro_31)PF16338(DUF4968)PF17137(DUF5110) | 5 | ASP A 470TRP A 511ASP A 659PHE A 692HIS A 740 | None | 0.87A | 3topB-2xvgA:33.4 | 3topB-2xvgA:24.87 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ctt | MALTASE-GLUCOAMYLASE (Homo sapiens) |
PF00088(Trefoil)PF01055(Glyco_hydro_31)PF16863(NtCtMGAM_N) | 10 | ASP A 203ASP A 327ILE A 364TRP A 406ASP A 443MET A 444ARG A 526ASP A 542PHE A 575HIS A 600 | GOL A3001 (-2.6A)3CU A1001 (-2.7A)3CU A1001 (-4.5A)None3CU A1001 (-2.7A)3CU A1001 ( 3.9A)3CU A1001 ( 3.5A)3CU A1001 ( 2.5A)3CU A1001 (-4.5A)3CU A1001 (-3.9A) | 0.51A | 3topB-3cttA:48.7 | 3topB-3cttA:43.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3lpp | SUCRASE-ISOMALTASE (Homo sapiens) |
PF00088(Trefoil)PF01055(Glyco_hydro_31)PF16863(NtCtMGAM_N) | 10 | ASP A 231ASP A 355ILE A 392TRP A 435ASP A 472MET A 473ARG A 555ASP A 571PHE A 604HIS A 629 | NoneTRS A6001 (-2.9A)NoneTRS A6001 ( 4.6A)TRS A6001 (-3.2A)TRS A6001 ( 3.7A)TRS A6001 ( 4.6A)TRS A6001 ( 3.7A)TRS A6001 (-4.4A)TRS A6001 (-4.2A) | 0.45A | 3topB-3lppA:48.7 | 3topB-3lppA:41.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3lpp | SUCRASE-ISOMALTASE (Homo sapiens) |
PF00088(Trefoil)PF01055(Glyco_hydro_31)PF16863(NtCtMGAM_N) | 7 | ASP A 231ASP A 472LYS A 509ARG A 555ASP A 571PHE A 604HIS A 629 | NoneTRS A6001 (-3.2A)NoneTRS A6001 ( 4.6A)TRS A6001 ( 3.7A)TRS A6001 (-4.4A)TRS A6001 (-4.2A) | 0.95A | 3topB-3lppA:48.7 | 3topB-3lppA:41.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3lpp | SUCRASE-ISOMALTASE (Homo sapiens) |
PF00088(Trefoil)PF01055(Glyco_hydro_31)PF16863(NtCtMGAM_N) | 5 | ASP A 600ASP A 394ILE A 356ASP A 355ASP A 571 | NoneNoneTRS A6001 ( 4.0A)TRS A6001 (-2.9A)TRS A6001 ( 3.7A) | 1.47A | 3topB-3lppA:48.7 | 3topB-3lppA:41.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3poc | ALPHA-GLUCOSIDASE (Blautia obeum) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 10 | ASP A 73LYS A 81ASP A 197ILE A 234TRP A 271MET A 308ARG A 404ASP A 420PHE A 453HIS A 478 | NoneNoneACR A 664 (-2.9A)NoneACR A 664 (-4.6A)ACR A 664 ( 3.8A)ACR A 664 (-4.0A)ACR A 664 (-2.8A)ACR A 664 (-4.4A)ACR A 664 (-4.2A) | 0.63A | 3topB-3pocA:38.6 | 3topB-3pocA:24.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3wel | ALPHA-GLUCOSIDASE (Beta vulgaris) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF16863(NtCtMGAM_N) | 10 | ASP A 232ASP A 357ILE A 396TRP A 432ASP A 469MET A 470ARG A 552ASP A 568PHE A 601HIS A 626 | ACR A1001 (-2.7A)ACR A1001 (-3.0A)ACR A1001 (-4.9A)ACR A1001 ( 4.6A)ACR A1001 (-3.2A)ACR A1001 (-3.3A)ACR A1001 (-3.0A)ACR A1001 (-2.7A)ACR A1001 (-4.3A)ACR A1001 (-4.1A) | 0.36A | 3topB-3welA:45.1 | 3topB-3welA:34.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4b9y | ALPHA-GLUCOSIDASE,PUTATIVE, ADG31B (Cellvibriojaponicus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF16338(DUF4968)PF17137(DUF5110) | 7 | ASP A 299ILE A 341ASP A 412ARG A 463ASP A 480PHE A 513HIS A 540 | None | 0.52A | 3topB-4b9yA:34.3 | 3topB-4b9yA:25.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5djw | ALPHA-GLUCOSIDASE II (Bacteroidesthetaiotaomicron) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF17137(DUF5110) | 5 | ASP A 211TRP A 285ARG A 385ASP A 401PHE A 434 | None | 1.44A | 3topB-5djwA:35.7 | 3topB-5djwA:26.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5djw | ALPHA-GLUCOSIDASE II (Bacteroidesthetaiotaomicron) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF17137(DUF5110) | 5 | ASP A 211TRP A 285ASP A 321ARG A 385PHE A 434 | None | 1.25A | 3topB-5djwA:35.7 | 3topB-5djwA:26.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5dkx | ALPHAGLUCOSIDASE-LIKEPROTEIN (Chaetomiumthermophilum) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF17137(DUF5110) | 10 | ASP A 303ASP A 443ILE A 480TRP A 517ASP A 556MET A 557ARG A 617ASP A 633PHE A 666HIS A 691 | NoneTRS A1001 (-2.9A)NoneTRS A1001 ( 4.9A)TRS A1001 (-3.2A)TRS A1001 (-3.5A)TRS A1001 (-4.0A)TRS A1001 (-2.8A)TRS A1001 (-4.5A)TRS A1001 (-4.0A) | 0.45A | 3topB-5dkxA:37.4 | 3topB-5dkxA:27.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5f7c | ALPHA-GLUCOSIDASE (Bacteroidesthetaiotaomicron) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 7 | ASP A 228ASP A 348ASP A 460ARG A 507ASP A 523PHE A 556HIS A 588 | None | 0.61A | 3topB-5f7cA:28.4 | 3topB-5f7cA:22.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5f7s | GLYCOSIDE HYDROLASEFAMILY 31 (Trueperellapyogenes) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 5 | ASP A 467ARG A 516ASP A 532PHE A 565HIS A 591 | CA A 805 (-2.9A) CA A 805 ( 4.6A) CA A 805 ( 4.6A)NoneNone | 0.67A | 3topB-5f7sA:31.1 | 3topB-5f7sA:22.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hjr | NEUTRALALPHA-GLUCOSIDASE AB (Mus musculus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 10 | ASP A 305ASP A 451ILE A 488TRP A 525ASP A 564MET A 565ARG A 624ASP A 640PHE A 673HIS A 698 | None5GF A1021 (-2.0A)None5GF A1021 (-3.7A)5GF A1021 (-2.1A)5GF A1021 (-2.6A)5GF A1021 (-3.4A)5GF A1021 (-2.6A)5GF A1021 (-3.6A)5GF A1021 (-4.0A) | 0.47A | 3topB-5hjrA:41.9 | 3topB-5hjrA:27.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hjr | NEUTRALALPHA-GLUCOSIDASE AB (Mus musculus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 5 | ASP A 640ASP A 305ARG A 624ASP A 564HIS A 492 | 5GF A1021 (-2.6A)None5GF A1021 (-3.4A)5GF A1021 (-2.1A)None | 1.43A | 3topB-5hjrA:41.9 | 3topB-5hjrA:27.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5jou | ALPHA-XYLOSIDASEBOGH31A (Bacteroidesovatus) |
PF01055(Glyco_hydro_31)PF16338(DUF4968)PF17137(DUF5110) | 6 | ASP A 441ASP A 553ARG A 613ASP A 630PHE A 663HIS A 709 | EDO A1008 (-2.8A)EDO A1008 (-2.7A)EDO A1008 (-4.6A)EDO A1008 (-3.0A)EDO A1008 (-4.3A)EDO A1008 (-4.0A) | 0.61A | 3topB-5jouA:32.1 | 3topB-5jouA:25.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5jou | ALPHA-XYLOSIDASEBOGH31A (Bacteroidesovatus) |
PF01055(Glyco_hydro_31)PF16338(DUF4968)PF17137(DUF5110) | 5 | ASP A 441TRP A 482ASP A 630PHE A 663HIS A 709 | EDO A1008 (-2.8A)NoneEDO A1008 (-3.0A)EDO A1008 (-4.3A)EDO A1008 (-4.0A) | 0.94A | 3topB-5jouA:32.1 | 3topB-5jouA:25.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5nn8 | LYSOSOMALALPHA-GLUCOSIDASE (Homo sapiens) |
no annotation | 10 | ASP A 282ASP A 404ILE A 441TRP A 481ASP A 518MET A 519ARG A 600ASP A 616PHE A 649HIS A 674 | ACR A1015 (-2.6A)ACR A1015 (-3.0A)ACR A1015 (-4.3A)ACR A1015 ( 4.6A)ACR A1015 (-3.1A)ACR A1015 (-3.3A)ACR A1015 (-3.1A)ACR A1015 (-2.7A)ACR A1015 (-4.3A)ACR A1015 (-4.0A) | 0.43A | 3topB-5nn8A:48.4 | 3topB-5nn8A:39.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5x7s | GLYCOSIDE HYDROLASEFAMILY 31ALPHA-GLUCOSIDASE (Paenibacillussp. 598K) |
PF01055(Glyco_hydro_31)PF16338(DUF4968)PF16990(CBM_35)PF17137(DUF5110) | 5 | ASP A 429ARG A 474ASP A 491PHE A 533HIS A 565 | None | 0.49A | 3topB-5x7sA:24.6 | 3topB-5x7sA:22.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1idu | VANADIUMCHLOROPEROXIDASE (Curvulariainaequalis) |
PF01569(PAP2) | 4 | PRO A 245ILE A 265TRP A 359PHE A 499 | None | 1.46A | 3topB-1iduA:0.0 | 3topB-1iduA:20.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2b2n | TRANSCRIPTION-REPAIRCOUPLING FACTOR (Escherichiacoli) |
no annotation | 4 | PRO A 213ILE A 257TRP A 73PHE A 122 | None | 1.25A | 3topB-2b2nA:undetectable | 3topB-2b2nA:17.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2eid | GALACTOSE OXIDASE (Fusariumgraminearum) |
PF00754(F5_F8_type_C)PF01344(Kelch_1)PF09118(DUF1929) | 4 | PRO A 4ILE A 140TRP A 105PHE A 146 | None | 1.32A | 3topB-2eidA:0.0 | 3topB-2eidA:22.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2eyq | TRANSCRIPTION-REPAIRCOUPLING FACTOR (Escherichiacoli) |
PF00270(DEAD)PF00271(Helicase_C)PF02559(CarD_CdnL_TRCF)PF03461(TRCF) | 4 | PRO A 213ILE A 257TRP A 73PHE A 122 | None | 1.17A | 3topB-2eyqA:0.1 | 3topB-2eyqA:21.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2pe4 | HYALURONIDASE-1 (Homo sapiens) |
PF01630(Glyco_hydro_56) | 4 | PRO A 249ILE A 225TRP A 141PHE A 212 | None | 1.24A | 3topB-2pe4A:3.9 | 3topB-2pe4A:19.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ri6 | 2-HYDROXY-6-OXO-6-PHENYLHEXA-2,4-DIENOATE HYDROLASE (Paraburkholderiaxenovorans) |
PF12697(Abhydrolase_6) | 4 | ILE A 182TRP A 269TRP A 266PHE A 239 | None | 1.27A | 3topB-2ri6A:undetectable | 3topB-2ri6A:15.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2vyc | BIODEGRADATIVEARGININEDECARBOXYLASE (Escherichiacoli) |
PF01276(OKR_DC_1)PF03709(OKR_DC_1_N)PF03711(OKR_DC_1_C) | 4 | PRO A 478ILE A 359TRP A 518PHE A 495 | None | 1.30A | 3topB-2vycA:1.5 | 3topB-2vycA:20.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xd3 | MALTOSE/MALTODEXTRIN-BINDING PROTEIN (Streptococcuspneumoniae) |
PF13416(SBP_bac_8) | 4 | PRO A 291ILE A 256TRP A 242TRP A 238 | None | 1.31A | 3topB-2xd3A:undetectable | 3topB-2xd3A:17.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2zux | YESW PROTEIN (Bacillussubtilis) |
no annotation | 4 | PRO A 570ILE A 493TRP A 548PHE A 59 | None | 1.50A | 3topB-2zuxA:undetectable | 3topB-2zuxA:21.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3hjh | TRANSCRIPTION-REPAIR-COUPLING FACTOR (Escherichiacoli) |
no annotation | 4 | PRO A 213ILE A 257TRP A 73PHE A 122 | None | 1.24A | 3topB-3hjhA:undetectable | 3topB-3hjhA:19.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3jq0 | SUSD SUPERFAMILYPROTEIN (Bacteroidesvulgatus) |
PF07980(SusD_RagB)PF14322(SusD-like_3) | 4 | PRO A 391ILE A 71TRP A 288PHE A 264 | None | 1.41A | 3topB-3jq0A:0.2 | 3topB-3jq0A:19.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3w6q | TYROSINASE (Aspergillusoryzae) |
PF00264(Tyrosinase) | 4 | PRO A 100ILE A 437TRP A 428PHE A 297 | None | 1.19A | 3topB-3w6qA:undetectable | 3topB-3w6qA:20.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4aqb | MANNAN-BINDINGLECTIN SERINEPROTEASE 1 (Homo sapiens) |
PF00084(Sushi)PF00431(CUB)PF14670(FXa_inhibition) | 4 | PRO A 265ILE A 216TRP A 290PHE A 259 | None | 1.47A | 3topB-4aqbA:undetectable | 3topB-4aqbA:17.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4e0q | COP9 SIGNALOSOMECOMPLEX SUBUNIT 6 (Drosophilamelanogaster) |
PF01398(JAB) | 4 | PRO A 178ILE A 64TRP A 137PHE A 182 | None | 1.47A | 3topB-4e0qA:undetectable | 3topB-4e0qA:10.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4n77 | UNCHARACTERIZEDPROTEIN (Thermusthermophilus) |
PF09704(Cas_Cas5d) | 4 | PRO A 210ILE A 6TRP A 15PHE A 214 | None | 1.32A | 3topB-4n77A:undetectable | 3topB-4n77A:13.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4up7 | LYSINE--TRNA LIGASE (Entamoebahistolytica) |
PF00152(tRNA-synt_2)PF01336(tRNA_anti-codon) | 4 | PRO A 445ILE A 537TRP A 533PHE A 375 | None | 1.16A | 3topB-4up7A:undetectable | 3topB-4up7A:23.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ye4 | HEAVY CHAIN HUMANANTIBODY HJ16LIGHT CHAIN OF HJ16 (Homo sapiens) |
PF07654(C1-set)PF07686(V-set) | 4 | PRO L 103ILE H 101TRP L 56PHE H 114 | None | 1.27A | 3topB-4ye4L:undetectable | 3topB-4ye4L:13.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5c70 | GLUCURONIDASE (Aspergillusoryzae) |
PF00703(Glyco_hydro_2)PF02836(Glyco_hydro_2_C)PF02837(Glyco_hydro_2_N) | 4 | PRO A 441ILE A 348TRP A 242PHE A 283 | None | 1.04A | 3topB-5c70A:9.5 | 3topB-5c70A:20.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5dkx | ALPHAGLUCOSIDASE-LIKEPROTEIN (Chaetomiumthermophilum) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF17137(DUF5110) | 4 | ILE A 444TRP A 554TRP A 630PHE A 667 | TRS A1001 ( 4.1A)TRS A1001 (-4.9A)NoneNone | 0.37A | 3topB-5dkxA:37.5 | 3topB-5dkxA:27.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hjr | NEUTRALALPHA-GLUCOSIDASE AB (Mus musculus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 4 | ILE A 452TRP A 562TRP A 637PHE A 674 | 5GF A1021 (-3.6A)5GF A1021 (-4.6A)5GF A1021 ( 4.6A)None | 0.35A | 3topB-5hjrA:41.9 | 3topB-5hjrA:27.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ik8 | LAMININ SUBUNITALPHA-2 (Mus musculus) |
PF00054(Laminin_G_1)PF02210(Laminin_G_2) | 4 | PRO A2753ILE A3084TRP A3021PHE A2931 | NoneNoneNoneEDO A4009 ( 4.4A) | 1.19A | 3topB-5ik8A:undetectable | 3topB-5ik8A:19.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5tu0 | LMO2125 PROTEIN (Listeriamonocytogenes) |
PF13416(SBP_bac_8) | 4 | PRO A 288ILE A 253TRP A 239TRP A 234 | NoneNoneNonePGE A 503 (-3.8A) | 1.35A | 3topB-5tu0A:undetectable | 3topB-5tu0A:19.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5uam | ULVAN LYASE-PL25 (Pseudoalteromonassp. PLSV) |
PF15892(BNR_4) | 4 | PRO A 227ILE A 257TRP A 297PHE A 203 | None | 1.35A | 3topB-5uamA:0.2 | 3topB-5uamA:18.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5uuj | ALKZ (Streptomycessahachiroi) |
PF06224(HTH_42) | 4 | PRO A 84ILE A 181TRP A 73PHE A 190 | None | 1.08A | 3topB-5uujA:undetectable | 3topB-5uujA:17.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6bo6 | - (-) |
no annotation | 4 | PRO A 453ILE A 359TRP A 259PHE A 294 | None | 1.21A | 3topB-6bo6A:9.0 | 3topB-6bo6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6d1q | RNAPYROPHOSPHOHYDROLASE (Escherichiacoli) |
no annotation | 4 | PRO B 132ILE B 111TRP B 33PHE B 35 | None | 1.00A | 3topB-6d1qB:undetectable | 3topB-6d1qB:7.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6dip | NOCTURNIN (Homo sapiens) |
no annotation | 4 | PRO A 233ILE A 179TRP A 172PHE A 216 | None | 1.44A | 3topB-6dipA:0.1 | 3topB-6dipA:6.39 |